Educational Session 6: ADCs in the Clinic
Session Details
This session will explore the evolving role of antibody-drug conjugates (ADCs) in breast cancer care, covering their use in early-stage disease, optimal sequencing in metastatic settings, and activity in patients with brain metastases, with perspectives from clinical experts and patient advocates.
Moderator
Adrienne G. Waks, Dana-Farber Cancer Institute, Boston, MA
Presentation numberED6-01
Moving on up: ADCs in early-stage breast cancer
Sibylle Loibl, Goethe University of Frankfurt, Frankfurt, Germany
Presentation numberED6-02
Positioning and sequencing of ADCs in metastatic breast cancer
Reshma L Mahtani, Baptist Health Miami Cancer Institute, Miami, FL
Presentation numberED6-03
Activity of ADCs in patients with brain metastases
Andrew J Brenner, University of Texas Health Science Center at San Antonio, San Antonio, TX
Advocate
Rosa Olmos, Con Cáncer y Con Metas, Barcelona, Spain